GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Regenerex Pharma Inc (OTCPK:PEPT) » Definitions » Price-to-Tangible-Book

PEPT (Regenerex Pharma) Price-to-Tangible-Book : (As of Sep. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Regenerex Pharma Price-to-Tangible-Book?

As of today (2024-09-21), Regenerex Pharma's share price is $0.00. Regenerex Pharma's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was $-0.02. Hence, Regenerex Pharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Regenerex Pharma's Price-to-Tangible-Book or its related term are showing as below:

PEPT's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.73
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Regenerex Pharma's share price is $0.00. Regenerex Pharma's Book Value per Sharefor the quarter that ended in Jun. 2024 was $-0.02. Hence, Regenerex Pharma's P/B Ratio of today is .


Regenerex Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Regenerex Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerex Pharma Price-to-Tangible-Book Chart

Regenerex Pharma Annual Data
Trend Nov10 Nov11 Nov12 Nov13 Nov14 Mar17 Mar18 Mar22 Mar23 Mar24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Regenerex Pharma Quarterly Data
Nov14 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Regenerex Pharma's Price-to-Tangible-Book

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenerex Pharma's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's Price-to-Tangible-Book falls into.



Regenerex Pharma Price-to-Tangible-Book Calculation

Regenerex Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=0.00/-0.016
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Regenerex Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenerex Pharma Business Description

Traded in Other Exchanges
N/A
Address
5348 Vegas Drive, Suite 177, Las Vegas, NV, USA, 89108
Regenerex Pharma Inc develops and markets Woundcare Healing products. The current product technology provides the Company with a number of complete wound care protocols to treat all wounds, such as diabetic ulcers, pressure ulcers, burns, and surgical wounds. Its product Xcellderma OTC a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds; Accelerex Sterile Wound Cream is for the treatment of a wide variety of chronic and acute wounds; and Accelerex Impregnated Sterile Wound Dressing use as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.

Regenerex Pharma Headlines

No Headlines